An observational study in Acromegaly and Pituitary Tumor, sponsored by Huashan Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-09-26.
Sponsored by Huashan Hospital · Observational
The major purpose of this study is to evaluate the changes of multiple organs in patients with growth hormone-secreting pituitary tumors before and after surgery. Plasma, DNA samples and pituitary tumor tissues will be kept for further analysis.
Multiple organs or systems will be affected by excessive growth hormones in patients with acromegaly. The major purpose of this study is to evaluate the changes before and after the pituitary surgery.
203 studies on the registry are indexed under Acromegaly; 19 are open to participants now.
This study's planned enrollment of 60 is below the median of 100 across 81 observational studies indexed under Acromegaly.
Browse Acromegaly studies →Huashan Hospital is the lead sponsor of 246 studies on the registry; 104 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The acromegaly patients at Huashan Hospital will be recruited anf followed up prior to surgery and one month, 3 months, 6 months and 12 months after surgery.
Inclusion Criteria:
This study is status unknown, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.